TY - JOUR A1 - Wagner, Birgit A1 - Hofmann, Laura A1 - Maaß, Ulrike T1 - Online-group intervention after suicide bereavement through the use of webinars T2 - Trials N2 - Introduction: The death of a significant person through suicide is a very difficult experience and can have long-term impact on an individual's psychosocial and physical functioning. However, there are only few studies that have examined the effects of interventions in suicide survivors. In the present study, we examine an online-group intervention for people bereaved by suicide using a group-webinar. Methods: The intervention was developed based on focus groups with the target group. The cognitive-behavioral 12-module webinar-based group intervention focuses on suicide bereavement-related themes such as feelings of guilt, stigmatization, meaning reconstruction and the relationship to the deceased. Further, the webinar includes testimonial videos and psychoeducation. The suicide survivors are randomized to the intervention or the waiting list in a group-cluster randomized controlled trial. Primary outcomes are suicidality (Beck Scale for Suicide Ideation) and depression (Beck Depression Inventory-II) and secondary outcomes are symptoms of prolonged grief disorder (Inventory of Complicated Grief-German Version ), posttraumatic stress disorder ( Revised Impact of Event Scale ), stigmatization (Stigma of Suicide and Suicide Survivor ) and posttraumatic cognitions (Posttraumatic Cognitions Inventory). Discussion: Previous studies of Internet-based interventions for the bereaved were based on writing interventions showing large treatment effects. Little is known about the use of webinars as group interventions. Advantages and challenges of this novel approach of psychological interventions will be discussed. KW - Suicide bereavement KW - grief KW - group intervention KW - webinar KW - suicidality KW - prolonged grief disorder KW - randomized controlled trial Y1 - 2020 UR - https://publishup.uni-potsdam.de/frontdoor/index/index/docId/57846 SN - 1468-6694 SN - 1745-6215 VL - 21 IS - 1 PB - BioMed Central CY - London ER -